Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 19 for:    sangamo
Previous Study | Return to List | Next Study

A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03432364
Recruitment Status : Recruiting
First Posted : February 14, 2018
Last Update Posted : July 10, 2019
Sponsor:
Collaborator:
Bioverativ Therapeutics Inc.
Information provided by (Responsible Party):
Sangamo Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2020
  Estimated Study Completion Date : December 2022